METHODS	Ninety-four prostatectomized men with rising prostrate-specific antigen ( PSA ) were enrolled into the placebo group ( 31 ) , monthly i.v. clodronate ( 39 ) or monthly i.v. zoledronic acid ( 24 ) groups for 36 months .\